Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells

Kumi Hirano, Tatsuki Ichikawa, Kazuhiko Nakao, Azusa Matsumoto, Hisamitsu Miyaaki, Hidetaka Shibata, Susumu Eguchi, Mitsuhisa Takatsuki, Masanori Ikeda, Hironori Yamasaki, Nobuyuki Kato, Takashi Kanematsu, Nobuko Ishi, Katsumi Eguchi

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The premise of our study is that selective inhibition of interferon (IFN) by calcineurin inhibitors contribute to the increased severity of hepatitis C virus (HCV) posttransplantation. Therefore, we examined the influence of calcineurin inhibitors in the human hepatocyte cell line on IFN-α-induced phosphorylation of Janus kinase (Jak) and signal transducers and activators of transcription (STAT), nuclear translocation of IFN-stimulated gene factor 3 (ISGF-3), IFN-stimulated regulatory element (ISRE)-contained promoter activity, and the expressions of antiviral proteins. Tacrolimus (Tac), but not cyclosporin A (CyA), had an inhibitory effect on IFN-α-induced double-stranded ribonucleic acid (RNA)-dependent protein kinase (PKR) in a dose-dependent manner. STAT-1 also acted in a similar fashion to PKR. IFN-α combined with Tac attenuated the ISRE-containing promoter gene activity as compared with IFN-α alone. In contrast, its expression in pretreated CyA was slightly attenuated. In pretreated Tac, but not CyA, the levels of IFN-α-induced tyrosine phosphorylated STAT-1 and -2 were clearly lower than those induced by IFN-α alone. Tac and CyA did not decrease the IFN-α-induced JAK-1 phosphorylation. The nuclear translocation rate of tyrosine phosphorylated STAT-1 was inhibited by pretreatment of both Tac and CyA by western blotting and immunohistochemistry. In an HCV replicon system, pretreated Tac diminished the replication inhibitory effect of IFN-α. In this study, we show that calcineurin inhibitors, especially Tac, are the negative regulators of IFN signaling in the hepatocyte; the greatest cause of such inhibition is the phosphorylation disturbance of STAT-1, next to inhibition of the nuclear translocation of STAT-1. In conclusion, disturbance of tyrosine phosphorylation of STAT-1 resulted in diminished ISRE-containing promoter activity and a decline in antiviral protein expression. Moreover, the replication of HCV was activated. This phenomenon is detrimental to IFN therapy after liver transplantation, and the selection of calcineurin inhibitors may warrant further discussion depending on the transplant situation.

Original languageEnglish
Pages (from-to)292-298
Number of pages7
JournalLiver Transplantation
Volume14
Issue number3
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Tacrolimus
Interferons
Cyclosporine
Antiviral Agents
Hepatocytes
STAT1 Transcription Factor
Proteins
Phosphorylation
Hepacivirus
Tyrosine
STAT2 Transcription Factor
Calcineurin Inhibitors
Interferon-Stimulated Gene Factor 3
eIF-2 Kinase
Janus Kinases
Replicon
Transducers
Liver Transplantation
Western Blotting
Immunohistochemistry

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells. / Hirano, Kumi; Ichikawa, Tatsuki; Nakao, Kazuhiko; Matsumoto, Azusa; Miyaaki, Hisamitsu; Shibata, Hidetaka; Eguchi, Susumu; Takatsuki, Mitsuhisa; Ikeda, Masanori; Yamasaki, Hironori; Kato, Nobuyuki; Kanematsu, Takashi; Ishi, Nobuko; Eguchi, Katsumi.

In: Liver Transplantation, Vol. 14, No. 3, 03.2008, p. 292-298.

Research output: Contribution to journalArticle

Hirano, K, Ichikawa, T, Nakao, K, Matsumoto, A, Miyaaki, H, Shibata, H, Eguchi, S, Takatsuki, M, Ikeda, M, Yamasaki, H, Kato, N, Kanematsu, T, Ishi, N & Eguchi, K 2008, 'Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells', Liver Transplantation, vol. 14, no. 3, pp. 292-298. https://doi.org/10.1002/lt.21358
Hirano, Kumi ; Ichikawa, Tatsuki ; Nakao, Kazuhiko ; Matsumoto, Azusa ; Miyaaki, Hisamitsu ; Shibata, Hidetaka ; Eguchi, Susumu ; Takatsuki, Mitsuhisa ; Ikeda, Masanori ; Yamasaki, Hironori ; Kato, Nobuyuki ; Kanematsu, Takashi ; Ishi, Nobuko ; Eguchi, Katsumi. / Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells. In: Liver Transplantation. 2008 ; Vol. 14, No. 3. pp. 292-298.
@article{cc5821d19a93480dbf8bef89813ae52d,
title = "Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells",
abstract = "The premise of our study is that selective inhibition of interferon (IFN) by calcineurin inhibitors contribute to the increased severity of hepatitis C virus (HCV) posttransplantation. Therefore, we examined the influence of calcineurin inhibitors in the human hepatocyte cell line on IFN-α-induced phosphorylation of Janus kinase (Jak) and signal transducers and activators of transcription (STAT), nuclear translocation of IFN-stimulated gene factor 3 (ISGF-3), IFN-stimulated regulatory element (ISRE)-contained promoter activity, and the expressions of antiviral proteins. Tacrolimus (Tac), but not cyclosporin A (CyA), had an inhibitory effect on IFN-α-induced double-stranded ribonucleic acid (RNA)-dependent protein kinase (PKR) in a dose-dependent manner. STAT-1 also acted in a similar fashion to PKR. IFN-α combined with Tac attenuated the ISRE-containing promoter gene activity as compared with IFN-α alone. In contrast, its expression in pretreated CyA was slightly attenuated. In pretreated Tac, but not CyA, the levels of IFN-α-induced tyrosine phosphorylated STAT-1 and -2 were clearly lower than those induced by IFN-α alone. Tac and CyA did not decrease the IFN-α-induced JAK-1 phosphorylation. The nuclear translocation rate of tyrosine phosphorylated STAT-1 was inhibited by pretreatment of both Tac and CyA by western blotting and immunohistochemistry. In an HCV replicon system, pretreated Tac diminished the replication inhibitory effect of IFN-α. In this study, we show that calcineurin inhibitors, especially Tac, are the negative regulators of IFN signaling in the hepatocyte; the greatest cause of such inhibition is the phosphorylation disturbance of STAT-1, next to inhibition of the nuclear translocation of STAT-1. In conclusion, disturbance of tyrosine phosphorylation of STAT-1 resulted in diminished ISRE-containing promoter activity and a decline in antiviral protein expression. Moreover, the replication of HCV was activated. This phenomenon is detrimental to IFN therapy after liver transplantation, and the selection of calcineurin inhibitors may warrant further discussion depending on the transplant situation.",
author = "Kumi Hirano and Tatsuki Ichikawa and Kazuhiko Nakao and Azusa Matsumoto and Hisamitsu Miyaaki and Hidetaka Shibata and Susumu Eguchi and Mitsuhisa Takatsuki and Masanori Ikeda and Hironori Yamasaki and Nobuyuki Kato and Takashi Kanematsu and Nobuko Ishi and Katsumi Eguchi",
year = "2008",
month = "3",
doi = "10.1002/lt.21358",
language = "English",
volume = "14",
pages = "292--298",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin A, on interferon-induced antiviral protein in human hepatocyte cells

AU - Hirano, Kumi

AU - Ichikawa, Tatsuki

AU - Nakao, Kazuhiko

AU - Matsumoto, Azusa

AU - Miyaaki, Hisamitsu

AU - Shibata, Hidetaka

AU - Eguchi, Susumu

AU - Takatsuki, Mitsuhisa

AU - Ikeda, Masanori

AU - Yamasaki, Hironori

AU - Kato, Nobuyuki

AU - Kanematsu, Takashi

AU - Ishi, Nobuko

AU - Eguchi, Katsumi

PY - 2008/3

Y1 - 2008/3

N2 - The premise of our study is that selective inhibition of interferon (IFN) by calcineurin inhibitors contribute to the increased severity of hepatitis C virus (HCV) posttransplantation. Therefore, we examined the influence of calcineurin inhibitors in the human hepatocyte cell line on IFN-α-induced phosphorylation of Janus kinase (Jak) and signal transducers and activators of transcription (STAT), nuclear translocation of IFN-stimulated gene factor 3 (ISGF-3), IFN-stimulated regulatory element (ISRE)-contained promoter activity, and the expressions of antiviral proteins. Tacrolimus (Tac), but not cyclosporin A (CyA), had an inhibitory effect on IFN-α-induced double-stranded ribonucleic acid (RNA)-dependent protein kinase (PKR) in a dose-dependent manner. STAT-1 also acted in a similar fashion to PKR. IFN-α combined with Tac attenuated the ISRE-containing promoter gene activity as compared with IFN-α alone. In contrast, its expression in pretreated CyA was slightly attenuated. In pretreated Tac, but not CyA, the levels of IFN-α-induced tyrosine phosphorylated STAT-1 and -2 were clearly lower than those induced by IFN-α alone. Tac and CyA did not decrease the IFN-α-induced JAK-1 phosphorylation. The nuclear translocation rate of tyrosine phosphorylated STAT-1 was inhibited by pretreatment of both Tac and CyA by western blotting and immunohistochemistry. In an HCV replicon system, pretreated Tac diminished the replication inhibitory effect of IFN-α. In this study, we show that calcineurin inhibitors, especially Tac, are the negative regulators of IFN signaling in the hepatocyte; the greatest cause of such inhibition is the phosphorylation disturbance of STAT-1, next to inhibition of the nuclear translocation of STAT-1. In conclusion, disturbance of tyrosine phosphorylation of STAT-1 resulted in diminished ISRE-containing promoter activity and a decline in antiviral protein expression. Moreover, the replication of HCV was activated. This phenomenon is detrimental to IFN therapy after liver transplantation, and the selection of calcineurin inhibitors may warrant further discussion depending on the transplant situation.

AB - The premise of our study is that selective inhibition of interferon (IFN) by calcineurin inhibitors contribute to the increased severity of hepatitis C virus (HCV) posttransplantation. Therefore, we examined the influence of calcineurin inhibitors in the human hepatocyte cell line on IFN-α-induced phosphorylation of Janus kinase (Jak) and signal transducers and activators of transcription (STAT), nuclear translocation of IFN-stimulated gene factor 3 (ISGF-3), IFN-stimulated regulatory element (ISRE)-contained promoter activity, and the expressions of antiviral proteins. Tacrolimus (Tac), but not cyclosporin A (CyA), had an inhibitory effect on IFN-α-induced double-stranded ribonucleic acid (RNA)-dependent protein kinase (PKR) in a dose-dependent manner. STAT-1 also acted in a similar fashion to PKR. IFN-α combined with Tac attenuated the ISRE-containing promoter gene activity as compared with IFN-α alone. In contrast, its expression in pretreated CyA was slightly attenuated. In pretreated Tac, but not CyA, the levels of IFN-α-induced tyrosine phosphorylated STAT-1 and -2 were clearly lower than those induced by IFN-α alone. Tac and CyA did not decrease the IFN-α-induced JAK-1 phosphorylation. The nuclear translocation rate of tyrosine phosphorylated STAT-1 was inhibited by pretreatment of both Tac and CyA by western blotting and immunohistochemistry. In an HCV replicon system, pretreated Tac diminished the replication inhibitory effect of IFN-α. In this study, we show that calcineurin inhibitors, especially Tac, are the negative regulators of IFN signaling in the hepatocyte; the greatest cause of such inhibition is the phosphorylation disturbance of STAT-1, next to inhibition of the nuclear translocation of STAT-1. In conclusion, disturbance of tyrosine phosphorylation of STAT-1 resulted in diminished ISRE-containing promoter activity and a decline in antiviral protein expression. Moreover, the replication of HCV was activated. This phenomenon is detrimental to IFN therapy after liver transplantation, and the selection of calcineurin inhibitors may warrant further discussion depending on the transplant situation.

UR - http://www.scopus.com/inward/record.url?scp=41149127169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149127169&partnerID=8YFLogxK

U2 - 10.1002/lt.21358

DO - 10.1002/lt.21358

M3 - Article

C2 - 18306331

AN - SCOPUS:41149127169

VL - 14

SP - 292

EP - 298

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 3

ER -